arrow_back Back to App

Expanded Research and Education for Endometrial Cancer

This act aims to boost research into endometrial cancer and enhance public education about it. It focuses on reducing disparities in diagnosis and treatment, especially among African-American women, potentially leading to earlier detection and better treatment outcomes for all women.
Key points
Expand endometrial cancer research by the National Institutes of Health (NIH), including studies on disparities in incidence and mortality.
Establish a public education program on endometrial cancer by the Centers for Disease Control and Prevention (CDC), with materials specifically for African-American women.
Ensure appropriate representation of African-American women in NIH-supported clinical trials for endometrial cancer, proportional to their incidence rates.
Authorize funding for these initiatives for fiscal years 2026 through 2028.
article Official text account_balance Process page
Introduced
Citizen Poll
100%
0%
Additional Information
Print number: 119_HR_5239
Sponsor: Rep. Scott, David [D-GA-13]
Process start date: 2025-09-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Endometrial Cancer Research and Education Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5239.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-09.

What are the main provisions?

Key points include:

  • Expand endometrial cancer research by the National Institutes of Health (NIH), including studies on disparities in incidence and mortality.
  • Establish a public education program on endometrial cancer by the Centers for Disease Control and Prevention (CDC), with materials specifically for African-American women.
  • Ensure appropriate representation of African-American women in NIH-supported clinical trials for endometrial cancer, proportional to their incidence rates.
  • Authorize funding for these initiatives for fiscal years 2026 through 2028.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Scott, David [D-GA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health